Clinical Trial Update: Metabolic Effects of Natriuretic Peptide Hormones [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating metabolic effects of natriuretic peptide hormones was terminated, with results posted in December 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Drugs mentioned

• Natriuretic peptide hormones (natriuretic peptide hormones)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Obesity, Cardiovascular Physiological Phenomena | Phase 4 | Status: TERMINATED | Results posted: 2023-12-15